Cargando…
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
Estrogen-receptor-negative breast cancer (BCER−) is mainly treated with chemotherapeutics. Leptin signaling can influence BCER− progression, but its effects on patient survival and chemoresistance are not well understood. We hypothesize that leptin signaling decreases the survival of BCER− patients...
Autores principales: | Lipsey, Crystal C., Harbuzariu, Adriana, Robey, Robert W., Huff, Lyn M., Gottesman, Michael M., Gonzalez-Perez, Ruben R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311967/ https://www.ncbi.nlm.nih.gov/pubmed/32471192 http://dx.doi.org/10.3390/ijms21113794 |
Ejemplares similares
-
Leptin signaling and cancer chemoresistance: Perspectives
por: Candelaria, Pierre V, et al.
Publicado: (2017) -
Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer
por: Harmon, Tia, et al.
Publicado: (2017) -
Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance
por: Daley-Brown, Danielle, et al.
Publicado: (2019) -
Leptin-Notch signaling axis is involved in pancreatic cancer progression
por: Harbuzariu, Adriana, et al.
Publicado: (2016) -
Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer
por: Harbuzariu, Adriana, et al.
Publicado: (2018)